CLINICAL_TRIALS
trial_result
· 2024-11-25
Clinical Trial Update: A Study of Seltorexant in Participants With Probable Alzheimer's Disease [Phase 2]
Summary
Phase 2 study evaluating Seltorexant in participants with probable Alzheimer's disease has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Research & Development, LLC | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-11-25